Announcements
Keep up to date with Isogenica’s latest news on collaborations and press releases.
Isogenica’s
Latest News
PRESS RELEASES
Isogenica is proud to announce two new Non-Executive Directors
Isogenica is pleased to welcome both Paul Clewlow and Trevor Phillips as our new Non-Executive Directors to the team.
Isogenica announces two Pioneering Collaborations with an Antibody Research and License Agreement, and an Asset Evaluation Deal
Isogenica, a leading innovator in VHH antibodies, is proud to unveil two significant collaborations, demonstrating the company’s commitment to advancing healthcare through cutting-edge research and development.
University of Leicester strikes partnership with biotech experts Isogenica to develop personalised cancer treatments
Patients could benefit from bespoke cancer-fighting treatments with fewer side effects thanks to a new partnership between a biotech company and a UK university.
Announcements
Catch up on Isogenica’s latest activities.
Why is Cancer so Hard? Claudia Fernandes tell us her thoughts…
In our second edition of Why is Cancer so Hard? we chat to Claudia Fernandes, Alliances Manager, about her take on why cancer is so difficult to treat and, eventually, cure:
Llamas: leading the pack in new cancer therapy, BioScience Today’s article on Isogenica’s VHH discovery
Llamas: leading the pack in new cancer therapy, BioScience Today’s article on Isogenica’s VHH discovery
Isogenica renews collaboration with the Royal Academy of Engineering to support students from under-represented groups
We are delighted to be working with the Royal Academy of Engineering as part of their Graduate Engineering Engagement Programme (GEEP).